In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

January 22, 2024
Motley Rice Fights DQ Bid In Opioid MDL

Law firms representing governments suing over the opioid epidemic on Monday told an Ohio federal judge that "corporate wrongdoers" don't get to pick who sues them, in response to a pharmacy benefit manager's bid to disqualify Motley Rice LLC over its representation of other governments in prescription drug disputes.
December 15, 2023
Motley Rice 'Weaponized' Gov. Info For Opioid MDL, PBM Says

An online pharmacy defending itself amid multidistrict litigation launched by state attorneys general over the opioid epidemic urged a federal judge Friday to disqualify Motley Rice LLC, saying the plaintiffs' firm "weaponized" confidential information it received while investigating on behalf of the government.
October 31, 2023
6th Circ. Asked To Step Into Opioid Special Master Row

Pharmacy benefit managers have urged the Sixth Circuit to remove a special master from the opioid multidistrict litigation in Ohio federal court over an accidental reply-all email, saying it showed he had made up his mind even before discovery took place.
October 10, 2023
Email Flub In Opioid MDL No Basis For Master's Removal

The Ohio federal judge overseeing the opioid multidistrict litigation on Tuesday refused to remove a special master who misfired a "reply all" email, saying it "unquestionably" contained private deliberations.
September 28, 2023
Opioid Special Master's Email Doesn't Betray Bias, Court Told

The plaintiffs' executive committee in multidistrict opioid litigation against pharmacy benefit managers OptumRX Inc. and Express Scripts Inc. has urged an Ohio federal court to reject their bid to disqualify the special master who sent a misfired "reply all" email.
September 21, 2023
Opioid MDL Special Master Fights Bias DQ For 'Email Mistake'

The special master overseeing the massive opioid multidistrict litigation against pharmacy benefit managers OptumRX Inc. and Express Scripts Inc. is fighting a disqualification bid filed following his reply-all flub, telling an Ohio federal judge on Thursday that it is "hokey" but true that every day he reminds himself of the role's "honor and privilege."
September 20, 2023
Opiate MDL Special Master Faces DQ Bid Over 'Reply All' Goof

Pharmacy benefit managers OptumRX Inc. and Express Scripts Inc. called for the disqualification of the special master overseeing multidistrict litigation brought against the PBMs over the national opioid epidemic after he allegedly revealed a bias against them in an email they said he inadvertently sent as a "reply all."
September 12, 2023
Opioid Sales Fell By Half After 2010, DEA Data Shows

Newly released data from the U.S. Drug Enforcement Administration about prescription opioid sales shows that opioid shipments in 2019 were nearly half of those a decade prior, attorneys in the sweeping opioid litigation said on Tuesday.
August 22, 2023
Walmart's Opioid Deal Advances With States' Participation

Walmart revealed in a regulatory filing late Tuesday that it will pay about $2.8 billion of the roughly $3 billion deal it struck to end thousands of lawsuits accusing its nationwide pharmacy network of fueling America's opioid crisis, after an administrator determined enough municipalities have joined the state settlements.
July 14, 2023
DEA Must Produce Data For Opioid MDL Trials, Judge Rules

The Ohio federal judge steering multidistrict litigation over the opioid crisis on Friday signed off on a subpoena requesting information on national opioid sales from the U.S. Drug Enforcement Administration, saying the data's importance to the litigation "cannot be overstated."

← Previous
1
2
3
4
5
6
7
8
9
…
Next →